PartnershipsMetagenomi also leverages several collaborations with Ionis and Affini-T, which could be a good source of continued non-dilutive funds as development advances.
Product DevelopmentUpdated data from the Hem A program demonstrate stable FVIII levels, suggesting a strong product profile and providing validation for the secreted protein platform.
Technology AdvancementsMGX demonstrated advancements in technology with a system that allows large targeted genome integration in human cells.